Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
Johnson and Johnson
Baxter
Medtronic

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022532


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 022532 describes BEYAZ, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the BEYAZ profile page.

The generic ingredient in BEYAZ is drospirenone; ethinyl estradiol; levomefolate calcium. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
Summary for 022532
Suppliers and Packaging for NDA: 022532
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532 NDA AUTHORIZED GENERIC Sandoz Inc 0781-4075 0781-4075-15 3 BLISTER PACK in 1 CARTON (0781-4075-15) > 1 KIT in 1 BLISTER PACK (0781-4075-52)
BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-407 50419-407-00 90 BLISTER PACK in 1 PACKAGE (50419-407-00) > 1 KIT in 1 BLISTER PACK
Paragraph IV (Patent) Challenges for 022532
Tradename Dosage Ingredient NDA Submissiondate
BEYAZ TABLET;ORAL drospirenone; ethinyl estradiol; levomefolate calcium 022532 2012-11-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG,N/A;0.02MG,N/A;0.451MG,0.451MG
Approval Date:Sep 24, 2010TE:ABRLD:No
Patent:  Start TrialPatent Expiration:Jul 30, 2022Product Flag?Substance Flag?YDelist Request?
Patent:  Start TrialPatent Expiration:Dec 20, 2021Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Mar 3, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY

Expired US Patents for NDA 022532

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.